SCHEMBL6017397

SCHEMBL6017397

CCN(CC)CC(=O)N1CCC(Oc2cc3c(Nc4ccc(OCc5cccc(F)c5)c(OC)c4)ncnc3cc2OC)CC1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.60
ERBB2 P04626 5/20 0.57
GAK O14976 1/20 0.57
ERBB4 Q15303 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5564452 0.94 EGFR (0.61) EGFRERBB2GAKERBB4
SCHEMBL5570038 0.89 EGFR (0.70) EGFRERBB2GAKERBB4
SCHEMBL5564631 0.88 EGFR (0.57) EGFRERBB2GAK
SCHEMBL5568894 0.86 EGFR (0.64) EGFRERBB2GAKERBB4
SCHEMBL3420740 0.83 EGFR (0.85) EGFRERBB2GAK
SCHEMBL1446950 0.82 EGFR (0.69) EGFRERBB2GAKERBB4
SCHEMBL12743454 0.81 EGFR (0.75) EGFRERBB2GAKERBB4
SCHEMBL5569341 0.81 EGFR (0.68) EGFRERBB2
SCHEMBL1446460 0.80 EGFR (0.78) EGFRERBB2GAKERBB4
SCHEMBL1446379 0.79 EGFR (0.72) EGFRERBB2GAKERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664028-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS AstraZeneca AB (SE) 2006-06-07 EP disclosed
WO-2005026151-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2005-03-24 WO disclosed